Search Results - "Gant, C. M"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities

    Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities by Gant, C. M, Oosterwijk, M. M, Binnenmars, S. H, Navis, G. J, Haverkate, H, Bakker, S. J. L, Laverman, G. D

    Published in BMC nephrology (16-08-2023)
    “…Abstract Objective Pharmacological inhibition of the renin-angiotensin-aldosterone-system (RAASi) is the cornerstone of hypertension treatment, renoprotection…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance

    Serotype distribution and antimicrobial resistance of invasive pneumococcal disease strains in the Comunidad Valenciana, Spain, during the winter of 2009-2010: low PCV7 coverage and high levofloxacin resistance by Gant, C M, Rosingh, A W, López-Hontangas, J L, van der Heijden, M, González-Morán, F, Bijlsma, J J E, Canton, E

    Published in Antimicrobial agents and chemotherapy (01-09-2012)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: